Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $53.4 Million - $59.7 Million
-1,433,127 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$35.49 - $43.02 $14.9 Million - $18 Million
-419,491 Reduced 22.64%
1,433,127 $57.9 Million
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $10.7 Million - $12 Million
-290,429 Reduced 13.55%
1,852,618 $70.4 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $12.3 Million - $14 Million
-352,739 Reduced 14.13%
2,143,047 $84.8 Million
Q2 2018

Aug 14, 2018

BUY
$34.55 - $37.05 $30.4 Million - $32.6 Million
878,923 Added 54.36%
2,495,786 $87.6 Million
Q1 2018

May 14, 2018

BUY
$32.97 - $36.63 $53.3 Million - $59.2 Million
1,616,863 New
1,616,863 $56.5 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $241B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track York Capital Management Global Advisors, LLC Portfolio

Follow York Capital Management Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of York Capital Management Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Capital Management Global Advisors, LLC with notifications on news.